Yassamin Ansari (D-AZ)
Premenstrual Dysphoric Disorder Awareness and Research Act of 2026
A Democratic bill with 29 Democratic cosponsors · See all 29 cosponsors
Last activity — Referred to the House Committee on Energy and Commerce.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
The Premenstrual Dysphoric Disorder Awareness and Research Act of 2026 aims to expand research, improve awareness, and increase access to treatment for those affected by PMDD. The bill directs the Secretary of Health and Human Services to intensify research regarding causes, risks, and treatments while supporting clinical trials. It also mandates a public health awareness campaign to raise awareness and reduce stigma. Additionally, the act provides for the development of medical education materials and the awarding of grants to train various health care professionals. Finally, the Secretary is required to submit a report to Congress on the progress of these initiatives.
Yes· 3 of 16
- Scored +7
Would women be better off under this?
The bill directly addresses Premenstrual Dysphoric Disorder, a condition primarily affecting women and individuals assigned female at birth.
- Scored +7
Does this make health care easier to get in general?
The legislation expands clinical research, public health awareness, and training grants to improve diagnosis and treatment for PMDD.
- Scored +7
Does this put more money into medical research?
The bill directs the NIH to expand and intensify research and clinical trials on Premenstrual Dysphoric Disorder.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Expanded Research and Treatment: The bill directs the NIH to intensify research into the causes, diagnosis, and treatment of PMDD, and supports clinical trials to develop better treatment options (Section 3(a)).
-
Increased Representation: Research efforts are directed to ensure that diverse racial, ethnic, and socioeconomic populations are adequately represented (Section 3(a)).
-
Better Data Collection: The Secretary is tasked with collecting and publishing data regarding the prevalence of PMDD and its economic and workforce impacts (Section 3(b)).
-
Public Awareness and Stigma Reduction: A public health campaign will be used to raise awareness among patients and providers, which aims to reduce the stigma of menstrual health conditions (Section 4(a)).
-
Improved Provider Knowledge: The bill mandates the development of education materials so that health care providers can more accurately diagnose PMDD and provide evidence-based care (Section 4(b)).
-
Professional Training Programs: Through grants, the Secretary can expand or establish training programs for various health care professionals, including physicians, nurses, and pharmacists, to improve PMDD management (Section 5(c)).
-
Expanded Health Services: Training opportunities may be expanded to support primary and specialty care services for mid-life women's health and related chronic conditions (Section 5(e)).
Potential Negative Impacts for People
- No negative impacts or burdens are explicitly mentioned in the text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Demographic And Interest Groups
- Would women be better off under this? — The bill directly addresses Premenstrual Dysphoric Disorder, a condition primarily affecting women and individuals assigned female at birth. Would people in middle age be better off under this? — Middle-aged individuals benefit from provisions supporting mid-life women's health and management of related conditions. Would students be better off under this? — The bill provides training opportunities and grants for students, trainees, and residents in healthcare fields. Would people in their twenties and thirties be better off under this? — Young adults of reproductive age benefit from early detection, awareness, and improved treatment options for PMDD. Would Black Americans be better off under this? — The legislation requires diverse racial and ethnic populations to be adequately represented in PMDD-related research. Would Asian Americans be better off under this? — The legislation requires diverse racial and ethnic populations to be adequately represented in PMDD-related research. Would Hispanic Americans be better off under this? — The legislation requires diverse racial and ethnic populations to be adequately represented in PMDD-related research. Would households on low incomes be better off under this? — The bill explicitly mandates the inclusion of diverse socioeconomic populations in research to help address healthcare disparities. Would Native Americans be better off under this? — The legislation requires diverse racial and ethnic populations to be adequately represented in PMDD-related research.
- Healthcare
- Does this make health care easier to get in general? — The legislation expands clinical research, public health awareness, and training grants to improve diagnosis and treatment for PMDD. Does this put more money into medical research? — The bill directs the NIH to expand and intensify research and clinical trials on Premenstrual Dysphoric Disorder. Does this make mental health care easier to get? — The bill improves mental health access by expanding treatment, awareness, and provider training for Premenstrual Dysphoric Disorder.
- Social Issues And Justice
- Does this narrow the gap between how men and women are treated? — The legislation focuses on a prevalent, under-researched medical condition affecting women and people assigned female at birth. Does this narrow racial gaps in how people are treated? — The bill ensures adequate representation of diverse racial, ethnic, and socioeconomic populations in PMDD-related research.
- Education And Technology
- Does this put more money into scientific research? — The bill authorizes appropriations and expands funding for medical research and clinical trials related to PMDD.
- Governance And Ideology
- Does this make what the government does easier for the public to see? — The bill mandates surveillance data collection and requires a formal progress report submitted to Congress within two years.
- 6/24/2026
- 1 Cosponsor added.
- 6/3/2026
- 1 Cosponsor added.
- 5/7/2026
- 1 Cosponsor added.
- 4/13/2026
- 1 Cosponsor added.
- 4/2/2026
- 2 Cosponsors added.
- 3/30/2026
- Referred to the House Committee on Energy and Commerce.
- 23 Cosponsors added.
- Introduced in House
Suzanne BonamiciDemocrat · Oregon
Joyce BeattyDemocrat · Ohio
Julia BrownleyDemocrat · California
Wesley BellDemocrat · Missouri
Yvette ClarkeDemocrat · New York
Troy CarterDemocrat · Louisiana
Herbert ConawayDemocrat · New Jersey
Lizzie FletcherDemocrat · Texas
Daniel GoldmanDemocrat · New York
Adelita GrijalvaDemocrat · Arizona
Henry JohnsonDemocrat · Georgia
Pramila JayapalDemocrat · Washington
Jonathan JacksonDemocrat · Illinois
Raja KrishnamoorthiDemocrat · Illinois
Timothy KennedyDemocrat · New York
Morgan McGarveyDemocrat · Kentucky
April McClain DelaneyDemocrat · Maryland
Sarah McBrideDemocrat · Delaware
Eleanor NortonDemocrat · District of Columbia
Ayanna PressleyDemocrat · Massachusetts
Deborah RossDemocrat · North Carolina
Paul TonkoDemocrat · New York
Rashida TlaibDemocrat · Michigan
Lori TrahanDemocrat · Massachusetts
Shri ThanedarDemocrat · Michigan
Lauren UnderwoodDemocrat · Illinois
Nydia VelázquezDemocrat · New York
Nikema WilliamsDemocrat · Georgia
Frederica WilsonDemocrat · Florida